<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Sex hormones: progestogens; Progestogens: menstrual disorders; Progesterone; Dydrogesterone: menstrual disorders; Medroxyprogesterone: menstrual disorders; Norgestrel; Endometriosis; Menorrhagia; Premenstrual syndrome; Abortion: habitual see Miscarriage, recurrent; Miscarriage, recurrent; Hormone replacement: progestogens; Progestogens: HRT" /><meta name="IX" content="Sex hormones: progestogens; Progestogens: menstrual disorders; Progesterone; Dydrogesterone: menstrual disorders; Medroxyprogesterone: menstrual disorders; Norgestrel; Endometriosis; Menorrhagia; Premenstrual syndrome; Miscarriage, recurrent; Hormone replacement: progestogens; Progestogens: HRT" /><meta name="IXN" content="Abortion: habitual see Miscarriage, recurrent" /><title>6.4.1.2 Progestogens and progesterone receptor modulators: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP4486-progestogens-and-progesterone-receptor-modulators.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP4486-progestogens-and-progesterone-receptor-modulators.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP4486-progestogens-and-progesterone-receptor-modulators.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP4031-endocrine-system.htm">6 Endocrine system</a> &gt; <a href="PHP4382-sex-hormones.htm">6.4 Sex hormones</a> &gt; <a href="PHP4383-female-sex-hormones-and-their-modulators.htm">6.4.1 Female sex hormones and their modulators</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP4484-raloxifene-hydrochloride.htm" title="Previous: RALOXIFENE HYDROCHLORIDE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP4489-dydrogesterone.htm" title="Next: DYDROGESTERONE">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1><span>6.4.1.2 </span>Progestogens and progesterone receptor modulators</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int664-progestogens.htm">Progestogens</a>).</p></div></div><p>There are two main groups of progestogen, progesterone and its analogues (dydrogesterone and medroxyprogesterone) and testosterone analogues (norethisterone and norgestrel). The newer progestogens (desogestrel, norgestimate, and gestodene) are all derivatives of norgestrel; levonorgestrel is the active isomer of norgestrel and has twice its potency. Progesterone and its analogues are less androgenic than the testosterone derivatives and neither progesterone nor dydrogesterone causes virilisation.</p><p>Where endometriosis requires drug treatment, it may respond to a progestogen, e.g. norethisterone, administered on a continuous basis. Danazol and gonadorelin analogues are also available (<a title=" Drugs affecting gonadotrophins" href="PHP4722-drugs-affecting-gonadotrophins.htm">section 6.7.2</a>).</p><p>Although oral progestogens have been used widely for menorrhagia they are relatively ineffective compared with tranexamic acid (<a title=" Antifibrinolytic drugs and haemostatics" href="PHP1589-antifibrinolytic-drugs-and-haemostatics.htm">section 2.11</a>) or, particularly where dysmenorrhoea is also a factor, mefenamic acid (<a title="monograph: MEFENAMIC ACID" href="PHP6486-mefenamic-acid.htm">section 10.1.1</a>); the levonorgestrel-releasing intra-uterine system (<a title=" Intra-uterine progestogen-only contraceptive" href="PHP4973-intra-uterine-progestogen-only-device.htm">section 7.3.2.3</a>) may be particularly useful for women also requiring contraception. Oral progestogens have also been used for severe dysmenorrhoea, but where contraception is also required in younger women the best choice is a combined oral contraceptive (<a title=" Combined oral contraceptives" href="PHP4869-combined-hormonal-contraceptives.htm">section 7.3.1</a>).</p><p>Progestogens have also been advocated for the alleviation of premenstrual symptoms, but no convincing physiological basis for such treatment has been shown.</p><p>Progestogens have been used for the prevention of miscarriage in women with a history of recurrent miscarriage but there is no evidence of benefit and they are <strong>not</strong> recommended for this purpose. In pregnant women with antiphospholipid antibody syndrome who have suffered recurrent miscarriage, administration of low-dose aspirin (<a title="section: Antiplatelet drugs" href="PHP1519-antiplatelet-drugs.htm">section 2.9</a>) and a prophylactic dose of a low molecular weight heparin (<a title="sub-section: Parenteral anticoagulants" href="PHP1441-parenteral-anticoagulants.htm">section 2.8.1</a>) may decrease the risk of fetal loss (use under specialist supervision only).</p><div><h2>Hormone replacement therapy</h2><p>In women with a uterus a progestogen needs to be added to long-term oestrogen therapy for hormone replacement, to prevent cystic hyperplasia of the endometrium and possible transformation to cancer; it can be added on a cyclical or a continuous basis (<a title="topic: Hormone replacement therapy" href="PHP4405-hormone-replacement-therapy.htm">see section 6.4.1.1</a>). Combined packs incorporating suitable progestogen tablets are available, see <a title="preparation-group: Conjugated oestrogens with progestogen" href="PHP4428-conjugated-oestrogens-with-progestogen.htm#PHP4428-conjugated-oestrogens-with-progestogen">Oestrogens for HRT</a>.</p></div><div><h2>Oral contraception</h2><p>Desogestrel, etynodiol (ethynodiol), gestodene, levonorgestrel, norethisterone, and norgestimate are used in combined oral contraceptives and in progestogen-only contraceptives (<a title=" Combined oral contraceptives" href="PHP4869-combined-hormonal-contraceptives.htm">section 7.3.1</a> and <a title=" Progestogen-only contraceptives" href="PHP4943-progestogen-only-contraceptives.htm">section 7.3.2</a>).</p></div><div><h2>Cancer</h2><p>Progestogens also have a role in neoplastic disease (<a title=" Progestogens" href="PHP5736-progestogens.htm">section 8.3.2</a>).</p></div><div id="PHP4487"><h2>Cautions</h2><p>Progestogens should be used with caution in conditions that may worsen with fluid retention e.g. epilepsy, hypertension, migraine, asthma, or cardiac dysfunction, and in those susceptible to thromboembolism (particular caution with high dose). Care is also required in those with a history of depression. Progestogens can decrease glucose tolerance and patients with diabetes should be monitored closely. For <strong>interactions</strong> see Appendix 1 (progestogens).</p></div><div id="PHP4488"><h2>Contra-indications</h2><p>Progestogens should be avoided in patients with a history of liver tumours. They are also contra-indicated in those with genital or breast cancer (unless progestogens are being used in the management of these conditions), severe arterial disease, undiagnosed vaginal bleeding and acute porphyria (<a title="sub-section: Acute porphyrias" href="PHP6363-acute-porphyrias.htm">section 9.8.2</a>). Progestogens should not be used if there is a history during pregnancy of idiopathic jaundice, severe pruritus, or pemphigoid gestationis.</p></div><div><h2>Side-effects</h2><p>Side-effects of progestogens include menstrual disturbances, premenstrual-like syndrome (including bloating, fluid retention, breast tenderness), weight change, nausea, headache, dizziness, insomnia, drowsiness, depression, change in libido; also skin reactions (including urticaria, pruritus, rash, and acne), hirsutism and alopecia. Jaundice and anaphylactoid reactions have also been reported.</p></div></div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP4489-dydrogesterone.htm" title="DYDROGESTERONE">DYDROGESTERONE</a></li><li id="_PHP4491-medroxyprogesterone-acetate"><a href="PHP4491-medroxyprogesterone-acetate.htm" title="MEDROXYPROGESTERONE ACETATE">MEDROXYPROGESTERONE ACETATE</a></li><li id="_PHP4497-norethisterone"><a href="PHP4497-norethisterone.htm" title="NORETHISTERONE">NORETHISTERONE</a></li><li id="_PHP4504-progesterone"><a href="PHP4504-progesterone.htm" title="PROGESTERONE">PROGESTERONE</a></li><li id="_PHP18438-progesterone-receptor-modulators"><a href="PHP18438-progesterone-receptor-modulators.htm" title="Progesterone receptor modulators">Progesterone receptor modulators</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP4484-raloxifene-hydrochloride.htm">Previous: RALOXIFENE HYDROCHLORIDE</a> | <a class="top" href="PHP4486-progestogens-and-progesterone-receptor-modulators.htm#">Top</a> | <a accesskey="]" href="PHP4489-dydrogesterone.htm">Next: DYDROGESTERONE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>